OXOID LIMITED
- Shared products
- CLOSTRIDIUM DIFFICILE (CLOSTRIDIOIDES DIFFICILE), COMBINED PARAMETERS IN THE SAME PRODUCT - CLASS II, CULTURE MEDIA AND DEVICES FOR MEDIA ENRICHMENT, STREPTOCOCCUS
- Shared products
- CLOSTRIDIUM DIFFICILE (CLOSTRIDIOIDES DIFFICILE), COMBINED PARAMETERS IN THE SAME PRODUCT - CLASS II, ESCHERICHIA COLI
- Shared products
- CLOSTRIDIUM DIFFICILE (CLOSTRIDIOIDES DIFFICILE), COMBINED PARAMETERS IN THE SAME PRODUCT - CLASS II, STREPTOCOCCUS
- Shared products
- CLOSTRIDIUM DIFFICILE (CLOSTRIDIOIDES DIFFICILE), COMBINED PARAMETERS IN THE SAME PRODUCT - CLASS II, STREPTOCOCCUS
- Shared products
- CLOSTRIDIUM DIFFICILE (CLOSTRIDIOIDES DIFFICILE), COMBINED PARAMETERS IN THE SAME PRODUCT - CLASS II, STREPTOCOCCUS
Explore comprehensive manufacturer profile for OXOID LIMITED based in United Kingdom through Pure Global AI's free Brazil medical device database. This manufacturer has 11 products registered with ANVISA across 9 unique technical categories. Their regulatory history spans from Apr 24, 2017 to May 26, 2025.
This page provides detailed insights including 5 recent product registrations including ESCHERICHIA COLI, 5 most popular products with STREPTOCOCCUS having 2 registrations, 1 registration holders including PHADIA DIAGNOSTICOS LTDA, and 5 key competitors with BECTON DICKINSON AND COMPANY (SPARKS) sharing 4 products. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, enabling global MedTech companies to analyze market dynamics and identify opportunities.